Cannabidiol and epilepsy in Brazil: a current review
Abstract Background: Cannabidiol (CBD) has become a promising therapeutic option in the treatment of epilepsy. Recent studies provide robust evidence…
Abstract Background: Cannabidiol (CBD) has become a promising therapeutic option in the treatment of epilepsy. Recent studies provide robust evidence…
Abstract The European Commission has determined that cannabidiol (CBD) can be considered as a novel food (NF), and currently, 19…
Abstract Background: Cannabis use among pregnant women has increased. We surveyed pregnant women in rural Pennsylvania to examine cannabis use…
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…
Abstract Introduction: This phase I open-label study examined pharmacokinetics, safety, and tolerability of escalating doses of a novel combination cannabinoid…
Abstract Introduction: Despite increasing demand for data, little is known about the authorization patterns, safety, and effectiveness of medical cannabis…
Abstract The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes…
Abstract Background: In 2017, the Jamaican government banned the sale of cannabis-infused edibles after reports of over-intoxication in adults and…
Abstract Objectives: The aim of this study was to determine the safety and tolerability of escalating doses of orally delivered…
Abstract Cannabidiol (CBD) is a biologically active, non-psychotropic component of Cannabis sativa whose popularity has grown exponentially in recent years.…